New York, NYNCT07257484Now EnrollingIRB Ready

Obesity (Disorder) Clinical Trial in New York, NY

Access cutting-edge obesity (disorder) treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Weill Medical College of Cornell University

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access obesity (disorder) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related obesity (disorder) treatment provided free

Apply for This New York Location

Check if you qualify for this obesity (disorder) clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Obesity (Disorder) Study in New York

This study will explore whether tirzepatide is a practical and acceptable treatment for postmenopausal females with a history of hormone receptor-positive breast cancer and obesity. The investigators aim to understand whether participants are willing and able to take this medication once weekly for 6 months and whether it may help improve weight and overall health. There will be monthly check-ins to monitor progress and safety. At the beginning and end of the study, participants will undergo body composition assessments, blood tests and a stool sample will be collected, and surveys will be completed.

Sponsor: Weill Medical College of Cornell University

Who Can Participate

Inclusion Criteria

Biologically female
Obesity as defined by current BMI ≥ 30 kg/m²
Postmenopausal as defined by one or more of the following
Age ≥60 years
Age \<60 years with amenorrhea for ≥ 1 year
Documented bilateral surgical oophorectomy
Chemical menopause with the addition of LHRH agonists at least 12 weeks prior to enrolment, and plan to remain on LHRH agonists throughout the trial
HR+ (ER and/or PR) stage 0-III breast cancer
Completed curative treatment (surgery, chemotherapy, radiotherapy) at least 12 weeks prior to enrolment
Insurance approval for tirzepatide or willing to pay out of pocket
Willing to provide informed consent and comply with study procedures

Exclusion Criteria

Stage IV breast cancer
Concomitant use of CDK inhibitors
Concomitant use of antiHER2 therapy
The PI may be consulted regarding enrollment of females receiving other endocrine therapy medications
Other active malignancy requiring treatment
Enrollment in another investigational clinical trial
Contraindication to tirzepatide
Treatment with a GLP-1 receptor agonist within the last 3 months
Diabetes requiring insulin
Any disorder, unwillingness, or inability, not covered by any of the other exclusion criteria, which in the investigator's opinion, might jeopardize the subject's safety or compliance with the protocol

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT07257484) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Obesity (Disorder) Treatment Options in New York, NY

If you're searching for obesity (disorder) treatment options in New York, NY, this clinical trial (NCT07257484) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obesity (disorder) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all obesity (disorder) clinical trials near you to find additional studies recruiting in your area.

More Obesity Trials in New York, NY

See all obesity clinical trials recruiting in New York — not just this study.

Browse Obesity Trials in New York

Browse More Trials by Condition

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY